1. Home
  2. CRAI vs AMPH Comparison

CRAI vs AMPH Comparison

Compare CRAI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

SELL

Current Price

$177.21

Market Cap

1.2B

ML Signal

SELL

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

SELL

Current Price

$26.42

Market Cap

1.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CRAI
AMPH
Founded
1965
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1998
2005

Fundamental Metrics

Financial Performance
Metric
CRAI
AMPH
Price
$177.21
$26.42
Analyst Decision
Hold
Hold
Analyst Count
2
7
Target Price
★ $250.50
$22.50
AVG Volume (30 Days)
87.5K
★ 479.1K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 1.29%
N/A
EPS Growth
★ 20.77
N/A
EPS
★ 8.14
0.81
Revenue
★ $751,583,000.00
$719,887,000.00
Revenue This Year
$8.35
$3.87
Revenue Next Year
$4.01
$4.90
P/E Ratio
★ $21.75
$32.62
Revenue Growth
★ 9.33
N/A
52 Week Low
$132.17
$16.65
52 Week High
$227.29
$29.52

Technical Indicators

Market Signals
Indicator
CRAI
AMPH
Relative Strength Index (RSI) 61.97 57.65
Support Level $153.02 $25.23
Resistance Level $194.00 $29.40
Average True Range (ATR) 4.99 0.82
MACD 0.99 -0.11
Stochastic Oscillator 85.50 39.08

Price Performance

Historical Comparison
CRAI
AMPH

About CRAI CRA International Inc.

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: